Moreover, we also showed that SGD treatment dose-dependently and significantly reversed the alteration in serum levels of hormone, i.e., SGD can reduce the serum levels of T and LH and increase the serum levels of E2 and FSH in PCOS rats. The gene discussed is BRD2; the disease is polycystic ovary syndrome.